Lindsay LaSalle is a Senior Staff Attorney with the Drug Policy Alliance’s Office of Legal Affairs and an expert and strategist in the areas of harm reduction and treatment as it relates to drug policy. In her role as an attorney, LaSalle has advocated for a public health approach to problematic drug use that is grounded in science and compassion and for alternative solutions to supply-side tactics and incarceration.

She drafts harm reduction, treatment, and health-related legislation across the country, including bills that provide legal protections for people who seek medical assistance in the event of an overdose, improve access to the overdose antidote naloxone, permit syringe exchange programs, remove barriers to treatment medications such as methadone and buprenorphine, authorize new interventions such as supervised consumption sites and drug checking services, and advance novel drug research. LaSalle also pushes back on attempts to criminalize overdose through, for instance, drug-induced homicide, involuntary commitment, or fentanyl mandatory minimum laws.

LaSalle has been published in peer-reviewed journals and also regularly drafts reports for the Drug Policy Alliance. She has testified before numerous legislative and government bodies in the United States, including the United States Sentencing Commission, and is regularly invited as an expert to present at conferences and universities.

She received both her B.A. and J.D. from the University of California, Berkeley, where she served as development editor of the California Law Review. Prior to joining DPA, LaSalle worked at Morrison & Foerster LLP for three years on commercial litigation matters, while maintaining an active pro bono practice.